Are GLP-1 Agonists New, and What Does the Safety Record Show?
GLP-1 receptor agonists have been in clinical use since 2005. This review covers their full development timeline, cardiovascular outcome trial data, thyroid cancer signals, pancreatitis risk, and what two decades of prescribing tell us about real-world safety.
Read clinical review